# A Safety And Pharmacokinetic Study With CVX-045 In Patients With Advanced Solid Tumors

> **NCT00879554** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 40 (actual)

## Conditions studied

- Advanced Solid Tumors
- Neoplasms
- Carcinoma
- Cancer
- Malignancy

## Interventions

- **BIOLOGICAL:** CVX-045

## Key facts

- **NCT ID:** NCT00879554
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2009-03
- **Final completion:** 2010-11
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2010-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00879554

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00879554, "A Safety And Pharmacokinetic Study With CVX-045 In Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00879554. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*